<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7BC6FCF2-358C-45C5-A5A7-E859DD754711"><gtr:id>7BC6FCF2-358C-45C5-A5A7-E859DD754711</gtr:id><gtr:name>Lund University</gtr:name><gtr:address><gtr:line1>Box 117</gtr:line1><gtr:line2>S-221 00</gtr:line2><gtr:line4>Lund</gtr:line4><gtr:postCode>S-221 00</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1F257D5A-AA9A-4460-9953-37368441A1EA"><gtr:id>1F257D5A-AA9A-4460-9953-37368441A1EA</gtr:id><gtr:name>University of Calgary</gtr:name><gtr:address><gtr:line1>2500 University Drive</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:department>Immunity and Infection</gtr:department><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7BC6FCF2-358C-45C5-A5A7-E859DD754711"><gtr:id>7BC6FCF2-358C-45C5-A5A7-E859DD754711</gtr:id><gtr:name>Lund University</gtr:name><gtr:address><gtr:line1>Box 117</gtr:line1><gtr:line2>S-221 00</gtr:line2><gtr:line4>Lund</gtr:line4><gtr:postCode>S-221 00</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1F257D5A-AA9A-4460-9953-37368441A1EA"><gtr:id>1F257D5A-AA9A-4460-9953-37368441A1EA</gtr:id><gtr:name>University of Calgary</gtr:name><gtr:address><gtr:line1>2500 University Drive</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/5D4C648B-9A53-4E4B-9A90-AF69814C66B0"><gtr:id>5D4C648B-9A53-4E4B-9A90-AF69814C66B0</gtr:id><gtr:firstName>Bertus</gtr:firstName><gtr:surname>Eksteen</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0601816"><gtr:id>812ADBC4-F083-41B1-B322-A45E7C676B64</gtr:id><gtr:title>Mucosal lymphocytes in the pathogenesis of Primary Sclerosing Cholangitis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0601816</gtr:grantReference><gtr:abstractText>Lymphocytes are a type of white blood cell and an important part of the body?s immune system which fights infections. Lymphocytes are directed to sites of infection by molecules called chemokines that are produced in response to inflammation. These chemokines are specific in that they can direct the recruitment of particular groups of lymphocytes to specific tissues. If these chemokines are produced inappropriately lymphocytes can be recruited into tissue where they attack healthy tissue rather than the infection. We have shown that in Primary Sclerosing Cholangitis (PSC), a chronic form of liver disease that is closely associated with uncontrolled inflammation in the gut that there is aberrant production of gut specific chemokines in the liver which subsequently allows lymphocytes from the gut to be recruited to the liver and inappropriately cause liver damage. In this study we propose to examine exactly how these molecules are involved in PSC and whether we could exploit them as novel pharmaceutical targets to develop new drugs in the future to treat chronic liver disease.</gtr:abstractText><gtr:technicalSummary>Hypothesis. 
Primary sclerosing cholangitis (PSC), a chronic inflammatory liver disease strongly associated with inflammatory bowel disease (IBD), is driven by the inappropriate recruitment of mucosal lymphocytes into the liver. 
I have shown that mucosal T cells are recruited to the liver in PSC and will now address their precise role in disease pathogenesis by determining 1) the factors that initiate this process and 2) the role of mucosal T cells in initiating extrahepatic disease. These studies will define a new paradigm in which extraintestinal autoimmune disease can be initiated by T cells activated in the gut.

Aims and Design
1. What signals regulate mucosal T-cell homing to the liver?
We will use in vitro methods to determine how T cells are imprinted with gut tropism and whether under specific circumstances this can occur in the liver. The factors responsible for aberrant expression of gut addressins in the liver will be determined by a) treating human cells in vitro with combinations of cytokines, TLR agonists and microenvironmental factors b) experiments in genetically manipulated mice which I have shown express MADCAM-1 in the liver. 
2. Murine models of PSC and in-vivo imaging
We will breed transgenic mice that express MAdCAM-1 and CCL25 in the liver and assess homing of gut T cells to the liver in adoptive transfer studies and in the setting of experimental IBD. These experiments will be initiated in the von Andrian lab in Harvard which is at the forefront of such work and where I will learn how to use multi-photon intra-vital microscopy to study homing to tissues in vivo.
3. Human in-vivo detection of mucosal lymphocytes.
I will generate T cells with a gut-homing phenotype and test their ability to home to the liver in patients with PSC using an indium111-based tracking protocol established in our group. Homing to the gut, liver, lungs and spleen will be assessed using scintigraphy to determine whether such cells show selective recruitment to the liver. We will use CCR9 and ?4?7 inhibitors that are currently undergoing phase 3 trials in IBD to determine the therapeutic potential of inhibiting these pathways. The facilities to carry out such studies to GMP standards are available through the National Blood Authority cell immunotherapy lab and the Wellcome Trust CRF.</gtr:technicalSummary><gtr:fund><gtr:end>2013-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1041153</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Harvard Medical School</gtr:department><gtr:description>Harvard University</gtr:description><gtr:id>BFF8290E-060F-402A-94F8-4B648D4201A9</gtr:id><gtr:impact>19233184, 17110582</gtr:impact><gtr:outcomeId>18FEA482676-1</gtr:outcomeId><gtr:partnerContribution>Development of novel research techniques and animal models</gtr:partnerContribution><gtr:piContribution>Development of novel research techniques and animal models</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Lund University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Lund University</gtr:description><gtr:id>A7A0281B-ABC1-4543-87E6-244C2C8586B9</gtr:id><gtr:impact>18710932</gtr:impact><gtr:outcomeId>B8E03591919-1</gtr:outcomeId><gtr:partnerContribution>Development of new assays and collaborative research</gtr:partnerContribution><gtr:piContribution>Development of new assays and collaborative research</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Calgary</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>University of Calgary</gtr:description><gtr:id>C5B12386-3362-4D84-96D6-1EF41EAEF6CB</gtr:id><gtr:impact>American Liver Foundation PSC seed grant awarded to Dr Eksteen $100000</gtr:impact><gtr:outcomeId>pNK3iNYAuVG-1</gtr:outcomeId><gtr:partnerContribution>Improved imaging of reseach samples</gtr:partnerContribution><gtr:piContribution>Joint research programme to expand imaging of T cells in PSC models. This had led to collaborative research and an American Liver Foundation research grant</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>IBD-PSC scientific meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EFBD6695-199E-44B3-9E82-97A725D4E07B</gtr:id><gtr:impact>Invited talks to local, european and international meetings to disseminate research findings which included BSG liver immunity meeting 2008, EASL meeting - Germany 2008, 2011

Increased scientific collaborators and access to research material. Transfer of Knowledge</gtr:impact><gtr:outcomeId>10A6AAEA763</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2008,2009,2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Research Abstracts</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>ED93B4D7-7F81-43BD-8391-18121C81EC10</gtr:id><gtr:impact>American Association for the Study of Liver Disease 2008,2009,2010 meeting, British Society of Gastrenterology meeting 2008, 2009, 2010, FALK meeting - Germany 2008, 2010

Increased scientific collaborators and access to research material. Transfer of Knowledge</gtr:impact><gtr:outcomeId>F5D7B65CEE3</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2008,2009,2010,2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Bowel disease research fund</gtr:description><gtr:fundingOrg>Bowel Disease Research Foundation (BDRF)</gtr:fundingOrg><gtr:id>5BEA1AD8-02BF-4E1A-84AE-48B2E402F4D1</gtr:id><gtr:outcomeId>aPoDKYSmg5b0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>70000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>T regulatory cell infusion in PSC patients/UHB Charities</gtr:description><gtr:end>2012-10-02</gtr:end><gtr:fundingOrg>Queen Elizabeth Hospital Birmingham Charity (QEHB)</gtr:fundingOrg><gtr:id>49131F7C-51B4-4B13-922B-E77E9B3AA2F3</gtr:id><gtr:outcomeId>Y8ajcsQLNNX0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Liver Trust Research Grant</gtr:description><gtr:fundingOrg>British Liver Trust</gtr:fundingOrg><gtr:id>53A00067-6680-4EC0-BF54-04CAA1E3D23E</gtr:id><gtr:outcomeId>E53C387D4490</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>American Liver Foundation</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>American Liver Foundation</gtr:fundingOrg><gtr:id>18C58D90-9961-43F4-A98B-5DE39A4EB35C</gtr:id><gtr:outcomeId>pYEt23Lwxgv0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Centre grant</gtr:description><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>4593CBC1-2832-41EC-A761-E0B9615D200F</gtr:id><gtr:outcomeId>9B45B5D47BF0</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3000000</gtr:amountPounds><gtr:country>Canada</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Alberta Innovates</gtr:description><gtr:fundingOrg>Alberta Innovates Health Solutions</gtr:fundingOrg><gtr:id>178C2E83-B375-46A5-8337-D152B942D8F7</gtr:id><gtr:outcomeId>AVtCjoR4gLM0</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>New mouse model to assess biliary inflammation</gtr:description><gtr:id>2DEC9617-B587-420F-8355-2D67DDC84DE7</gtr:id><gtr:impact>Currently it is used for supprting data gathering which will be published in future</gtr:impact><gtr:outcomeId>A2C958C119F</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Biliary inflammation model</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Establishment of animal models of hepatitis and assessment by intra vital microscopy</gtr:description><gtr:id>1ACF285C-162E-4215-82A4-0EBAD5C64112</gtr:id><gtr:impact>Data currently being submitted for publication.</gtr:impact><gtr:outcomeId>3A4DCE6AF39</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Intra vital microscopy</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>selective KI of CCL25 in the liver</gtr:description><gtr:id>D9617F7F-51ED-4E73-A8CD-31BE9F4011FC</gtr:id><gtr:impact>novel research in future</gtr:impact><gtr:outcomeId>kqQSzHWv3jF</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Generation of EKS1 Tg mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>3F3AB2C8-5BC7-4348-B35D-145123482508</gtr:id><gtr:title>Monitoring hepatitis C infection in the liver allograft.</gtr:title><gtr:parentPublicationTitle>Canadian journal of gastroenterology = Journal canadien de gastroenterologie</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f991f5733bfdcb106e59df3e5664d189"><gtr:id>f991f5733bfdcb106e59df3e5664d189</gtr:id><gtr:otherNames>Eksteen B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0835-7900</gtr:issn><gtr:outcomeId>pm_14506_26_23516676</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60FC64EE-634C-4AE0-B707-44A16A02F0CB</gtr:id><gtr:title>Immunology of the gut and liver: a love/hate relationship.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/856c31f0b7d46b833b854dca3afb28a6"><gtr:id>856c31f0b7d46b833b854dca3afb28a6</gtr:id><gtr:otherNames>Adams DH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>BF07CBAFD95</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2E6FC2B-7707-41A5-B177-426314F2EC96</gtr:id><gtr:title>CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver.</gtr:title><gtr:parentPublicationTitle>Journal of hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/736816f8f545c53af3577861e58e44cd"><gtr:id>736816f8f545c53af3577861e58e44cd</gtr:id><gtr:otherNames>Oo YH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0168-8278</gtr:issn><gtr:outcomeId>pm_14506_26_22796894</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>858176CE-9A91-476D-AC32-51779C59191F</gtr:id><gtr:title>The survival of memory CD4+ T cells within the gut lamina propria requires OX40 and CD30 signals.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47608de08e91ddb07b2d43a31809a80a"><gtr:id>47608de08e91ddb07b2d43a31809a80a</gtr:id><gtr:otherNames>Withers DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>9A5A86B16E3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12CC743A-7FB9-448F-9F5A-47D1B1D8BEA6</gtr:id><gtr:title>Acute liver failure after administration of paracetamol at the maximum recommended daily dose in adults.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/575d681bb1b74e3ceecee651e52cfbed"><gtr:id>575d681bb1b74e3ceecee651e52cfbed</gtr:id><gtr:otherNames>Claridge LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>XCqdDjbkNxd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5600488-D64D-44DD-AEC5-96F18C8A9BF6</gtr:id><gtr:title>Mechanisms of disease: the evolving understanding of liver allograft rejection.</gtr:title><gtr:parentPublicationTitle>Nature clinical practice. Gastroenterology &amp; hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f991f5733bfdcb106e59df3e5664d189"><gtr:id>f991f5733bfdcb106e59df3e5664d189</gtr:id><gtr:otherNames>Eksteen B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1743-4378</gtr:issn><gtr:outcomeId>79E32253478</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6349F53-DBC9-44F2-9557-100BE4C94DFA</gtr:id><gtr:title>Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf8ffd99eab207a818d6f84f482dda72"><gtr:id>cf8ffd99eab207a818d6f84f482dda72</gtr:id><gtr:otherNames>Mora JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>9F23869A7A2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2BC004D-5C1C-40B5-8ABB-3F9619F1198C</gtr:id><gtr:title>Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53e1cb9cca7a479aee2a22fa697ff4c6"><gtr:id>53e1cb9cca7a479aee2a22fa697ff4c6</gtr:id><gtr:otherNames>Jaensson E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>8662875A30B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D348D2F-DAEF-4192-BF86-070FB3D1DB82</gtr:id><gtr:title>Infections and the liver.</gtr:title><gtr:parentPublicationTitle>Digestive diseases (Basel, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f991f5733bfdcb106e59df3e5664d189"><gtr:id>f991f5733bfdcb106e59df3e5664d189</gtr:id><gtr:otherNames>Eksteen B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0257-2753</gtr:issn><gtr:outcomeId>AuG77fHcBAf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72938504-8786-4365-A110-220924E8BF78</gtr:id><gtr:title>Differential ferritin expression is associated with iron deficiency in coeliac disease.</gtr:title><gtr:parentPublicationTitle>European journal of gastroenterology &amp; hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc2a5ec38a278217b3bed88e037a7848"><gtr:id>fc2a5ec38a278217b3bed88e037a7848</gtr:id><gtr:otherNames>Sharma N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0954-691X</gtr:issn><gtr:outcomeId>0747DD229E4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33E36611-3818-4304-8D6E-1279BB2BC30F</gtr:id><gtr:title>A role for the integrin alpha6beta1 in the differential distribution of CD4 and CD8 T-cell subsets within the rheumatoid synovium.</gtr:title><gtr:parentPublicationTitle>Rheumatology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9bc31252be239b748664879198afe47d"><gtr:id>9bc31252be239b748664879198afe47d</gtr:id><gtr:otherNames>Haworth O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1462-0324</gtr:issn><gtr:outcomeId>03818AAC7BB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>069D5137-10AE-4FE7-81D0-D9A0279EE405</gtr:id><gtr:title>Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/736816f8f545c53af3577861e58e44cd"><gtr:id>736816f8f545c53af3577861e58e44cd</gtr:id><gtr:otherNames>Oo YH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>StUf88Vp18u</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6AEC176-17EA-4717-8AE9-8ED86B361D98</gtr:id><gtr:title>Lymphocyte homing and its role in the pathogenesis of IBD.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f991f5733bfdcb106e59df3e5664d189"><gtr:id>f991f5733bfdcb106e59df3e5664d189</gtr:id><gtr:otherNames>Eksteen B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>0794FA921BC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96129EC5-CC50-48A0-9489-2487F0059FA3</gtr:id><gtr:title>Immune-mediated liver injury.</gtr:title><gtr:parentPublicationTitle>Seminars in liver disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f991f5733bfdcb106e59df3e5664d189"><gtr:id>f991f5733bfdcb106e59df3e5664d189</gtr:id><gtr:otherNames>Eksteen B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0272-8087</gtr:issn><gtr:outcomeId>FB93BE00AFF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42D9950A-4412-4C68-AFCE-97E327285212</gtr:id><gtr:title>Gut homing receptors on CD8 T cells are retinoic acid dependent and not maintained by liver dendritic or stellate cells.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f991f5733bfdcb106e59df3e5664d189"><gtr:id>f991f5733bfdcb106e59df3e5664d189</gtr:id><gtr:otherNames>Eksteen B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>1785840799B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D986DBD-BCA0-448C-B420-09FAEC983274</gtr:id><gtr:title>Understanding of chemoprophylaxis and concordance in inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>World journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/011e6f9337b68ae17d0ba62e55e5c516"><gtr:id>011e6f9337b68ae17d0ba62e55e5c516</gtr:id><gtr:otherNames>Low A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1007-9327</gtr:issn><gtr:outcomeId>KaAC5G8wZT9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1E34014-8803-45D5-8B4C-7BB25FA4EF83</gtr:id><gtr:title>[Acute liver failure after administration of paracetamol at the maximum recommended daily dose in adults].</gtr:title><gtr:parentPublicationTitle>Praxis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/575d681bb1b74e3ceecee651e52cfbed"><gtr:id>575d681bb1b74e3ceecee651e52cfbed</gtr:id><gtr:otherNames>Claridge LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1661-8157</gtr:issn><gtr:outcomeId>pm_14506_26_21792808</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38FF901E-5425-4337-8A6D-79D6BA944685</gtr:id><gtr:title>GSK-1605786, a selective small-molecule antagonist of the CCR9 chemokine receptor for the treatment of Crohn's disease.</gtr:title><gtr:parentPublicationTitle>IDrugs : the investigational drugs journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f991f5733bfdcb106e59df3e5664d189"><gtr:id>f991f5733bfdcb106e59df3e5664d189</gtr:id><gtr:otherNames>Eksteen B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1369-7056</gtr:issn><gtr:outcomeId>MC7PFpU3zEH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C23962A4-621D-45C1-8350-513BA33EF2F5</gtr:id><gtr:title>Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f08243406518279380370a3fd236f37"><gtr:id>4f08243406518279380370a3fd236f37</gtr:id><gtr:otherNames>Liu JZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_14506_26_23603763</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6E365E4-82EA-47C1-8435-9E3946A8381F</gtr:id><gtr:title>Role of IL-17A and neutrophils in fibrosis in experimental hypersensitivity pneumonitis.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b99082277f9920c63fad476e17961861"><gtr:id>b99082277f9920c63fad476e17961861</gtr:id><gtr:otherNames>Hasan SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>pm_14506_26_23453796</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99D0D8E0-F04C-428F-95F3-7E09E9C1921F</gtr:id><gtr:title>CCL25 and CCL28 promote alpha4 beta7-integrin-dependent adhesion of lymphocytes to MAdCAM-1 under shear flow.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Gastrointestinal and liver physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c52b1deea6d33589dd0d7adec320dbc6"><gtr:id>c52b1deea6d33589dd0d7adec320dbc6</gtr:id><gtr:otherNames>Miles A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0193-1857</gtr:issn><gtr:outcomeId>93F521D4F2C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E7FE10B-731F-42FA-8473-E861E13E269A</gtr:id><gtr:title>Vascular cell adhesion molecule 1 expression by biliary epithelium promotes persistence of inflammation by inhibiting effector T-cell apoptosis.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c09ab949db1e04a2c7b6f1ec3230524"><gtr:id>2c09ab949db1e04a2c7b6f1ec3230524</gtr:id><gtr:otherNames>Afford SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>585d31c59a3a83.72449222</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F336B3E-0B64-47F5-9B84-E82D1E85E75C</gtr:id><gtr:title>Clonal analysis reveals uniformity in the molecular profile and lineage potential of CCR9(+) and CCR9(-) thymus-settling progenitors.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8016d58bbcf460d195f65c2938961205"><gtr:id>8016d58bbcf460d195f65c2938961205</gtr:id><gtr:otherNames>Desanti GE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>LJTWTQQKJ3w</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601816</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>